Literature DB >> 8550268

Exposure to environmental tobacco smoke and the risk of heart attack.

J E Muscat1, E L Wynder.   

Abstract

BACKGROUND: Environmental tobacco smoke (ETS) increases the risk of heart disease in several epidemiological studies although the methods of assessing exposure have been incomplete. We determined the prevalence of ETS from various sources, and examined the association between ETS and the risk of myocardial infarction.
METHODS: A hospital-based case-control study of myocardial infarction was conducted from 1980 to 1990 by interviewing 114 case patients and 158 control subjects.
RESULTS: Among controls, the sources of ETS were the workplace (56%), childhood exposure (66%), home adult exposure (48%), car exposure (20%) and from trains or other surface transportation (4%). Compared to never smokers, the odds ratio (OR) for exposure to ETS during childhood was 0.97 (95% confidence intervals [Cl]: 0.53-1.46) for men and 0.92 (95% Cl: 0.5-1.86) for women. The adjusted OR associated with adult exposure was 1.5 (95% Cl: 0.9-2.6), although no trend was observed with the number of years of exposure. Women who were exposed to ETS in automobiles had an increased but non-significant risk (OR = 2.8, 95% Cl: 0.9-8.0).
CONCLUSION: Exposure to ETS comes from a variety of sources besides the spouse including parents, workplace employees and motorists. Exposure to ETS during childhood is not associated with an increased risk of heart disease. However, ETS exposure during adulthood increased the risk of myocardial infarction approximately 50% in this data although the findings were not statistically significant.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8550268     DOI: 10.1093/ije/24.4.715

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  9 in total

1.  Lung cancer from passive smoking at work.

Authors:  A J Wells
Journal:  Am J Public Health       Date:  1998-07       Impact factor: 9.308

2.  Working hours as a risk factor for acute myocardial infarction in Japan: case-control study.

Authors:  S Sokejima; S Kagamimori
Journal:  BMJ       Date:  1998-09-19

3.  Association between exposure to environmental tobacco smoke and the development of acute coronary syndromes: the CARDIO2000 case-control study.

Authors:  C Pitsavos; D B Panagiotakos; C Chrysohoou; J Skoumas; K Tzioumis; C Stefanadis; P Toutouzas
Journal:  Tob Control       Date:  2002-09       Impact factor: 7.552

4.  Epidemiologic studies of fatal and nonfatal cardiovascular disease and ETS exposure from spousal smoking.

Authors:  M Thun; J Henley; L Apicella
Journal:  Environ Health Perspect       Date:  1999-12       Impact factor: 9.031

5.  Risk assessment for heart disease and workplace ETS exposure among nonsmokers.

Authors:  K Steenland
Journal:  Environ Health Perspect       Date:  1999-12       Impact factor: 9.031

Review 6.  Workplace exposure to passive smoking and risk of cardiovascular disease: summary of epidemiologic studies.

Authors:  I Kawachi; G A Colditz
Journal:  Environ Health Perspect       Date:  1999-12       Impact factor: 9.031

7.  The association between secondhand smoke and the risk of developing acute coronary syndromes, among non-smokers, under the presence of several cardiovascular risk factors: The CARDIO2000 case-control study.

Authors:  Demosthenes B Panagiotakos; Christina Chrysohoou; Christos Pitsavos; Ioanna Papaioannou; John Skoumas; Christodoulos Stefanadis; Pavlos Toutouzas
Journal:  BMC Public Health       Date:  2002-05-24       Impact factor: 3.295

8.  Meta-analysis of the association between second-hand smoke exposure and ischaemic heart diseases, COPD and stroke.

Authors:  Florian Fischer; Alexander Kraemer
Journal:  BMC Public Health       Date:  2015-12-01       Impact factor: 3.295

9.  The Magnitude of Mortality from Ischemic Heart Disease Attributed to Occupational Factors in Korea - Attributable Fraction Estimation Using Meta-analysis.

Authors:  Jaehyeok Ha; Soo-Geun Kim; Domyung Paek; Jungsun Park
Journal:  Saf Health Work       Date:  2011-03-31
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.